For Payers

Affordable & Accessible

Subscription-based access to transformative medicines

The fee-for-service model wasn’t designed for gene therapy. Our payment model is.

Learn More

Eliminate Budgeting Risk
Link Cost to Value
Ensure Patient Access

Unique Challenges

A payment model that works for gene therapy

We understand that covering gene therapy can be challenging for employers and payers. The ultra high price tag, lightning strike nature, and limited data on efficacy all pose unique challenges. Our payment model solves for these challenges - eliminating budgeting risk, linking cost to value, and providing an affordable access option for payers to ensure patient access.

Our Solution

Quantile Health is solving the problem of patient access to gene therapies by creating a reimbursement platform that allows payers of all sizes to directly enter into subscription-based access agreements with drug manufacturers

Learn More